ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tesla, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TSLA
01. April 2023 19:11 ET
|
The Rosen Law Firm PA
NEW YORK, April 01, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tesla, Inc. (NASDAQ: TSLA) between February 19, 2019 and...
TSLA NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Tesla, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TSLA
17. März 2023 17:26 ET
|
The Rosen Law Firm PA
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tesla, Inc. (NASDAQ: TSLA) between February 19, 2019...
Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results
21. November 2022 09:00 ET
|
Oncotelic Therapeutics, Inc.
R&D cost reduced in excess of 95% while continuing expansion of our OT-101 clinical programs through our joint ventureG&A cost reduced by approximately 50%Net loss reduced by approximately...
Oncotelic Presenting Data for OT101 Against Diffuse Intrinsic Pontine Glioma (DIPG) at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
14. September 2022 08:15 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
Oncotelic Participating at Biotechgate Digital Partnering
17. August 2022 08:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
Ambarella’s Automotive AI SoC Achieves ASIL C Certification, Exceeding Functional Safety Levels of Competing Front ADAS Solutions
07. Juni 2022 05:00 ET
|
Ambarella
SANTA CLARA, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced that its CV2FS automotive AI perception system-on-chip (SoC)...
ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
01. September 2021 12:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), executed a binding term sheet with Autotelic Inc. to license AL-101...
Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
28. Februar 2019 07:00 ET
|
Canntab Therapeutics Limited
TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, OTCQB: CTABF, FSE: TBF1) (“Canntab” or the “Company”) is pleased to announce that it has entered into a supply and...
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
12. Februar 2019 07:30 ET
|
Canntab Therapeutics Limited
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the development of precision oral dose cannabis tablets and capsules,...
All Work and No Pay: Government Contractors Face Brunt of Regulations
13. Juni 2018 09:54 ET
|
US Federal Contractor Registration
St. Petersburg, Fla. , June 13, 2018 (GLOBE NEWSWIRE) -- The GSA’s notarized letter policy has left many U.S. government contractors outraged and without pay. In just a few months, it managed to...